COVID-19: National Institutes of Health begins study on allergic reactions to Pfizer, Moderna vaccines

The U.S. National Institutes of Health said Wednesday it had begun a mid-stage study to determine the risk of allergic reactions to Pfizer/BioNTech and Moderna vaccinations, as doubts grow over their full efficiency. This came after such reactions, including life-threatening episodes, known as anaphylaxis, were reported in the United States after vaccinations of Pfizer and Moderna shots. “The public understandably has been concerned about reports of rare, severe allergic reactions to the Moderna and Pfizer-BioNTech COVID-19 vaccines,” said Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. “The information…